Decatur Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
GCM
Decatur Capital Management's ELV Position: Q1 2017 in Review
Decatur Capital Management sold out of Elevance Health (ELV) in Q1 2017, closing a stake of 76,425 shares — an estimated $11M sold.
Decatur Capital Management first reported a position in ELV in Q3 2013 and held it in 14 quarters. The position peaked at $29M in Q1 2015. 795 funds tracked by Wall St. Rank hold ELV as of Q1 2017.
- Decatur Capital Management reported no remaining Elevance Health position as of Q1 2017 after selling out during the quarter.
- Decatur Capital Management sold 76,425 Elevance Health shares in Q1 2017, an estimated $11M.
- Decatur Capital Management first reported a position in Elevance Health in Q3 2013 and held it in 14 quarters.
- Decatur Capital Management's Elevance Health position peaked at $29M in Q1 2015.
- 795 funds tracked by Wall St. Rank held Elevance Health as of Q1 2017.
Based on Decatur Capital Management's 13F filing for Q1 2017, filed 27 Apr 2017.